About MAFLD
About MAFLD
Risk Test
Genetics
Patient Portal
Patients Resources
Patient Synergies
Resources
Media & Press
Press Releases
Media Information
Photo & Video Disclaimer
MAIDEN Social Media Ambassadors
Partnerships
About MAIDEN
Welcome
About MAIDEN
Leadership & Governance
Program & Initiative
Diversity, Inclusion and Equity
MAFLD Nomenclature
About MAFLD
About MAFLD
Risk Test
Genetics
Patient Portal
Patients Resources
Patient Synergies
Resources
Media & Press
Press Releases
Media Information
Photo & Video Disclaimer
MAIDEN Social Media Ambassadors
Partnerships
About MAIDEN
Welcome
About MAIDEN
Leadership & Governance
Program & Initiative
Diversity, Inclusion and Equity
MAFLD Nomenclature
Archives of APASL events
Back to
past conferences »
2023 »
2022 »
APASL STC 2022
Liver fibrosis in the era of MAFLD
Day 3
Session 1
Role of morphometry and artificial intelligence in liver biopsy
of suspected MAFLD
PROF. Julien Calderaro
Genetics and epigenetics of MAFLD
PROF. Mohammed Eslam
HCC post MAFLD, molecular changes and pathology
PROF. Valerie Paradis
Session
2
Novel mechanisms of hepatic stellate cells activation
PROF. Norifumi Kawada
Macrophage diversity & fibrosis
PROF. Frank Tacke
Cellular interactions: from microvesicles to exosomes
and beyond
PROF. Gyongyi Szabo
Use of organoids for the development of novel therapies
PROF. Meritxell Huch
Session 3
MAFLD in type 1 DM
Prof. Osama Hamdy